Rising Regulatory And Geopolitical Risks Will Undermine API Profits

AN

AnalystLowTarget

Not Invested

Community Contributor

Published

12 Aug 25

Updated

22 Apr 26

Views

14

22 Apr

€1.45

AnalystLowTarget's Fair Value

€1.00

45.0% overvalued

1Y

-45.9%

7D

-2.7%

Loading

1Y

-45.9%

7D

-2.7%

You can edit this narrative until Apr 23 12:10 PM. Then, changes will post as Updates.

Author's Valuation

€145.0% overvalued

AnalystLowTarget Fair Value

Shared on 22 Apr 26

EAPI: Lower Demand And Portfolio Cuts Will Weigh On Future Earnings

Analysts have cut their price target on Euroapi to €1 from €2, with the change framed around more cautious assumptions despite essentially unchanged fair value, discount rate, revenue growth, profit margin and future P/E inputs in the latest update. Analyst Commentary Bearish analysts cutting the price target on Euroapi to €1 from €2 are signaling a more cautious stance around the stock, even though their core valuation inputs such as fair value frameworks, discount rate, revenue growth, profit margin and future P/E assumptions are described as essentially unchanged.

2 views

Shared on 25 Mar 26

EAPI: Weaker 2026 Outlook And Portfolio Cuts Will Pressure Earnings Quality

Analysts have cut their price target on Euroapi to €1 from €2, with the shift broadly tied to ongoing caution reflected in recent research commentary that maintains a Sell stance and modest adjustments to revenue growth and profit margin assumptions. Analyst Commentary Recent research updates highlight a series of price target cuts on Euroapi, with bearish analysts reducing their fair value estimates while maintaining a cautious stance on the shares.

0 views

Shared on 10 Mar 26

Fair value Decreased 50%

EAPI: Weaker 2025 Guidance Will Pressure Margins And Future Earnings Quality

Analysts have cut their Euroapi price target from €2 to €1, reflecting updated assumptions that now factor in lower revenue growth expectations, much slimmer profit margins, and a significantly higher future P/E multiple. Analyst Commentary Recent price target revisions point to a cautious stance from bearish analysts, who appear focused on execution risks and the implications for Euroapi's valuation.

1 view

Shared on 24 Feb 26

EAPI: Lower 2025 Guidance And Reduced Multiple Will Shape Return Profile

Analysts have trimmed their price target on Euroapi to €2 from €2.50, citing updated assumptions on modest revenue growth, slightly higher profit margins, and a marginally lower future P/E multiple. Analyst Commentary Recent research points to a more cautious stance on Euroapi, with bearish analysts trimming their price targets to €2.

1 view

Shared on 09 Feb 26

EAPI: Lower 2025 Outlook And Cautious Stance Will Shape Return Profile

Analysts have lowered their price target on Euroapi from €2.50 to €2, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that collectively suggest a more cautious valuation stance. Analyst Commentary Bearish analysts have recently cut their price target on Euroapi from €2.50 to €2.

0 views

Shared on 25 Jan 26

EAPI: Execution Risks And Lower Outlook Will Shape Future Return Profile

Narrative update Analysts have trimmed their price target on Euroapi by €0.50 to €2.00, citing updated assumptions on revenue growth, profit margins and forward P/E that keep their stance cautious on the shares. Analyst Commentary Recent research has reinforced a cautious stance on Euroapi, with bearish analysts trimming their price targets to €2.00.

1 view

Shared on 10 Jan 26

EAPI: Lower Profitability Assumptions And New Partnership Will Shape Future Returns

Analysts have trimmed their price target on Euroapi to €2 from €2.50, citing softer assumptions around revenue growth, profit margins and a higher future P/E multiple as the key drivers of the reset. Analyst Commentary Bearish analysts are signalling a cautious stance on Euroapi by aligning around a lower price target of €2, narrowed from €2.50.

1 view

Shared on 19 Dec 25

Fair value Decreased 20%

EAPI: Higher Discount Rate Will Outweigh Benefits From New Corticosteroid Partnership

Analysts have slightly reduced their Euroapi price target, reflecting a modest reassessment of fair value. This adjustment accounts for a higher discount rate, even as long term profit margin assumptions edge up and revenue declines appear marginally less severe.

3 views

Valuator

Company Info

Notes

AnalystLowTarget Fair Value

€1

45.0% overvalued

Future estimation in

Revenue

Profit Margin

Future PE

Est. Revenue

$

Forecast revenue growth rate

2.53%

Historical revenue growth rate

-1.40%

Pharma revenue growth rate

0.55%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

6.47%

Calculation

€2.22m

Earnings '29

x

51.39x

PE Ratio '29

=

€114.07m

Market Cap '29

€114.07m

Market Cap '29

/

95.11m

No. shares '29

=

€1.20

Share Price '29

€1.20 Share Price '29

Discounted to 2026 @ 6.29% p.a.

=

€1.00

Fair Value '26